Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study

Pizzuti L;Marchetti P;Natoli C;Gamucci T;Santini D;Scinto AF;Iezzi L;Mentuccia L;D'Onofrio L;Botticelli A;Moscetti L;Sperati F;Botti C;Ferranti F;Buglioni S;Sanguineti G;Di Filippo S;Di Lauro L;Sergi D;Catenaro T;Tomao S;Giordano A;Maugeri-Sacca M;Barba M;Vici P

2017-01-01